Intervention
Placebo
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 10,132 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseNCT07717411 · 2026-11-30
RECRUITINGA Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)NCT07568236 · 2026-10-05
RECRUITINGThe Gut - PRO StudyNCT07413744 · 2026-10-01
RECRUITINGRole of Postpartum Furosemide in Recovery of Patients With Severe PreeclampsiaNCT07861685 · 2026-10-01
RECRUITINGA Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)NCT07840326 · 2026-10-01
RECRUITINGA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or ObesityNCT07843498 · 2026-09-30
RECRUITINGA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseaseNCT07843472 · 2026-09-30
RECRUITINGA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 DiabetesNCT07843485 · 2026-09-30
RECRUITINGA Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)NCT07823608 · 2026-09-17
RECRUITINGWeight and Metabolic Management StudyNCT07789223 · 2026-09-15
RECRUITINGA Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityNCT07803744 · 2026-09-11
RECRUITINGA Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)NCT07780656 · 2026-09-11
RECRUITINGThe Effect of Nicorandil on Rheumatoid Arthritis PatientsNCT07730723 · 2026-09-06
RECRUITINGCASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer TrialNCT06949800 · 2026-09-04
RECRUITINGA Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study ParticipantsNCT07784699 · 2026-09-02
RECRUITINGA Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityNCT07754474 · 2026-09-01
RECRUITINGA Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 AgonistsNCT07789106 · 2026-09-01
RECRUITINGHS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionNCT07123779 · 2026-09-01
RECRUITINGAtomoxetine in Melanocortin Obesity SyndromeNCT06899178 · 2026-09-01
RECRUITINGPrecision Depression Adalimumab TrialNCT07845604 · 2026-09-01
RECRUITINGLumateperone for Late-Life DepressionNCT07623135 · 2026-09-01
RECRUITINGStratification and Treatment in Early Psychosis Study - ENHANCENCT06778564 · 2026-09-01
RECRUITINGDesloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast CancerNCT07109817 · 2026-09-01
RECRUITINGTributyrin for Progressive Supranuclear Palsy (PSP): Virtual TrialNCT07863180 · 2026-09-01
RECRUITINGInterleukine-2 (IL-2) Plus Semaglutide in Alzheimer's DiseaseNCT07651319 · 2026-09-01
RECRUITINGAssessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's DiseaseNCT07840027 · 2026-09-01
RECRUITINGMETabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01
RECRUITINGA Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)NCT07816185 · 2026-08-31
RECRUITINGAMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose WeightNCT07720271 · 2026-08-31
RECRUITINGA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesNCT07743463 · 2026-08-31
RECRUITINGAnti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/ObesityNCT07065591 · 2026-08-30
RECRUITINGA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesNCT07743450 · 2026-08-28
RECRUITINGA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventNCT07783802 · 2026-08-27
RECRUITINGA Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1)NCT07780643 · 2026-08-27
RECRUITINGA Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)NCT07782996 · 2026-08-27
RECRUITINGA Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)NCT07780669 · 2026-08-27
RECRUITINGA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityNCT07794579 · 2026-08-26
RECRUITINGA Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With AsthmaNCT07732023 · 2026-08-25
RECRUITINGA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseNCT07737743 · 2026-08-24
RECRUITINGA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24
RECRUITINGA Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarNCT07754461 · 2026-08-24
RECRUITINGA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24
RECRUITINGA Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusNCT07775404 · 2026-08-21
RECRUITINGOral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 DiabetesNCT07804849 · 2026-08-20
RECRUITINGA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20
RECRUITINGRelapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaNCT07686263 · 2026-08-20
RECRUITINGA Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaNCT07772921 · 2026-08-20
RECRUITINGA Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in AdultsNCT07143448 · 2026-08-19
RECRUITINGA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusNCT07784725 · 2026-08-19
RECRUITINGA Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)NCT07636811 · 2026-08-17
RECRUITINGAn Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)NCT06996652 · 2026-08-17
RECRUITINGStudy of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLCNCT07777822 · 2026-08-14
RECRUITINGA Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderNCT07775300 · 2026-08-14
RECRUITINGResearch Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightNCT07770841 · 2026-08-12
RECRUITINGA First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or ObesityNCT07767175 · 2026-08-12
RECRUITINGPharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseNCT07685938 · 2026-08-12
RECRUITINGA Study of LY3971297 in Participants With Heart FailureNCT07547540 · 2026-08-11
RECRUITINGStudy to Assess the Effect and Safety of ALV-100 on Maintenance of Weight LossNCT07837973 · 2026-08-10
RECRUITINGA Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With HypertensionNCT07758634 · 2026-08-08
RECRUITINGA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)NCT07759245 · 2026-08-07
RECRUITINGCommon conditions
Obesity727Asthma495Schizophrenia415Diabetes Mellitus, Type 2366Type 2 Diabetes Mellitus326Rheumatoid Arthritis307Major Depressive Disorder300Hypertension288Alzheimer's Disease270Type 2 Diabetes265Heart Failure246Alzheimer Disease213Breast Cancer195Chronic Obstructive Pulmonary Disease188Multiple Sclerosis176Overweight176HIV Infections170Parkinson Disease166Parkinson's Disease160Pulmonary Disease, Chronic Obstructive136Diabetes127Diabetes Mellitus123Healthy103Prostate Cancer103Depression96
Leading sponsors
AstraZeneca337Eli Lilly and Company302GlaxoSmithKline239Novartis Pharmaceuticals200Pfizer187Boehringer Ingelheim177Hoffmann-La Roche149Merck Sharp & Dohme LLC146Janssen Research & Development, LLC97Sanofi86Amgen82Biogen73Bristol-Myers Squibb73Takeda70National Institute of Allergy and Infectious Diseases (NIAID)69
Trial status mix
COMPLETED6,466
TERMINATED1,003
RECRUITING878
UNKNOWN719
ACTIVE_NOT_RECRUITING424
WITHDRAWN310
NOT_YET_RECRUITING285
SUSPENDED25
ENROLLING_BY_INVITATION22
Phase mix
PHASE23,926
PHASE32,650
PHASE11,812
NA1,261
PHASE41,022
EARLY_PHASE1116
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.